General Information of the Compound
Compound ID
CP0148502
Compound Name
4-[[4-[[4-[(3R)-oxolan-3-yl]oxy-1,2-benzoxazol-3-yl]oxymethyl]piperidin-1-yl]methyl]oxan-4-ol
    Show/Hide
Synonyms
(R)-4-((4-(((4-(Tetrahydrofuran-3-yloxy)-1,2-benzisoxazol-3-yl)oxy)methyl)piperidin-1-yl)methyl)tetrahydro-2H-pyran-4-ol
1331782-27-4
4-[[4-[[4-[(3R)-oxolan-3-yl]oxy-1,2-benzoxazol-3-yl]oxymethyl]piperidin-1-yl]methyl]oxan-4-ol
BDBM50398598
CHEMBL2152922
DB12675
GTPL9059
NCGC00386746-01
PF 04995274
PF-04995274
PF-04995274, &gt
PF04995274
SCHEMBL619629
UNII-XI179PG9LV
WLLOFQROROXOMO-GOSISDBHSA-N
XI179PG9LV
ZINC95577747
compound 2d [PMID: 22974325]
    Show/Hide
Structure
Formula
C23H32N2O6
Molecular Weight
432.517
Canonical SMILES
OC1(CN2CCC(COc3noc4cccc(O[C@@H]5CCOC5)c34)CC2)CCOCC1
    Show/Hide
InChI
InChI=1S/C23H32N2O6/c26-23(7-12-27-13-8-23)16-25-9-4-17(5-10-25)14-29-22-21-19(30-18-6-11-28-15-18)2-1-3-20(21)31-24-22/h1-3,17-18,26H,4-16H2/t18-/m1/s1
    Show/Hide
InChIKey
WLLOFQROROXOMO-GOSISDBHSA-N
CAS
1331782-27-4
Physicochemical Property
logP
2.6278
Rotatable Bonds
7
Heavy Atom Count
31
Polar Areas
86.42
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
8
Complexity
31

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 53354764
SID: 125239007
ChEMBL ID
CHEMBL2152922
DrugBank ID
DB12675
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01307, 5-hydroxytryptamine receptor 4
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  7
1
EC50 = 0.2 nM
   TI
   LI
   LO
   TS
2
EC50 = 0.26 nM
   TI
   LI
   LO
   TS
3
EC50 = 0.36 nM
   TI
   LI
   LO
   TS
4
EC50 = 0.47 nM
   TI
   LI
   LO
   TS
5
Ki = 0.15 nM
   TI
   LI
   LO
   TS
6
Ki = 0.36 nM
   TI
   LI
   LO
   TS
7
Ki = 0.46 nM
   TI
   LI
   LO
   TS
CL000011 CHO Cricetulus griseus (Chinese hamster)  3
1
EC50 = 1.3 nM
   TI
   LI
   LO
   TS
2
EC50 = 1.5 nM
   TI
   LI
   LO
   TS
3
Ki = 0.32 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 EC50 = 0.26 nM
Protein ID: PT01897, 5-hydroxytryptamine receptor 4
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  3
1
EC50 = 0.59 nM
   TI
   LI
   LO
   TS
2
EC50 = 0.62 nM
   TI
   LI
   LO
   TS
3
EC50 = 0.65 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( PF-04995274 )
Drug Name PF-04995274
Company Pfizer Inc
Indication
Alzheimer disease
Phase 1
Target(s)
5-HT 4 receptor (HTR4)
Agonist